Lauro S, Trasatti L, Capalbo C, Conti A, Ricci F, Mingazzini P L, Vecchione A
Chair of Medical Oncology, La Sapienza University of Rome, 2nd Faculty of Medicine and Surgery, Azienda Policlinico S. Andrea, Via di Grottarossa 1035, 00189, Rome, Italy.
Anticancer Res. 2002 Nov-Dec;22(6B):3643-5.
The metastatic involvement of the spleen in epithelial ovarian cancer is rare and usually reflects late disseminated disease. Isolated parenchymal metastasis in the spleen is an extremely unusual event, in fact in most cases in medical literature, the spleen was involved as part of diffuse peritoneal carcinomatosis. We report a rare case of epithelial ovarian carcinoma, which recurred in the splenic parenchyma 15 years after initial treatment. The patient underwent a splenectomy followed by six cycles of platinum-based poly-chemotherapy. Currently, 8 years after splenectomy, the patient has no evidence of relapsed disease. In the solitary splenic recurrence of epithelial ovarian cancer our case suggests that accurate surgical resection of the spleen, followed by platinum-based chemotherapy, is correlated with a prolonged survival.
上皮性卵巢癌发生脾脏转移很少见,通常提示疾病已处于晚期播散阶段。脾脏孤立性实质转移是极其罕见的情况,实际上在医学文献中的大多数病例中,脾脏是作为弥漫性腹膜癌病的一部分而受累。我们报告1例罕见的上皮性卵巢癌病例,该患者在初始治疗15年后脾脏实质出现复发。患者接受了脾切除术,随后进行了6个周期的铂类联合化疗。目前,脾切除术后8年,患者无疾病复发迹象。对于上皮性卵巢癌孤立性脾脏复发,我们的病例提示,准确的脾脏手术切除,随后进行铂类化疗,与生存期延长相关。